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Abstract We have investigated the protein interactions involved
in the assembly of pancreatic L-cell ATP-sensitive potassium
channels. The channels are a heterooligomeric complex of pore-
forming Kir6.2 subunits and sulfonylurea receptor (SUR1)
subunits. SUR1 belongs to the ATP binding cassette (ABC)
family of proteins and has two nucleotide binding domains
(NBD1 and NBD2) and 17 putative transmembrane (TM)
sequences. Previously we showed that co-expression in a
baculovirus expression system of two parts of SUR1 divided at
Pro1042 between TM12 and 13 leads to restoration of
glibenclamide binding activity, whereas expression of either
individual N- or C-terminal domain alone gave no glibenclamide
binding activity [M.V. Mikhailov and S.J.H. Ashcroft (2000)
J. Biol. Chem. 275, 3360^3364]. Here we show that the two half-
molecules formed by division of SUR1 between NBD1 and
TM12 or between TM13 and 14 also self-assemble to give
glibenclamide binding activity. However, deletion of NBD1 from
the N-part of SUR1 abolished SUR1 assembly, indicating a
critical role for NBD1 in SUR1 assembly. We found that
differences in glibenclamide binding activity obtained after co-
expression of different half-molecules are attributable to
different amounts of binding sites, but the binding affinities
remained nearly the same. Simultaneous expression of Kir6.2
resulted in enhanced glibenclamide binding activity only when the
N-half of SUR1 included TM12. We conclude that TM12 and
13 are not essential for SUR1 assembly whereas TM12 takes
part in SUR1 Kir6.2 interaction. This interaction is specific for
Kir 6.2 because no enhancement of glibenclamide binding was
observed when half-molecules were expressed together with
Kir4.1. We propose a model of KATP channel organisation based
on these data. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
A central component of transmembrane signalling in the
pancreatic L-cell is the ATP-sensitive potassium (KATP) chan-
nel which couples changes in plasma glucose concentration to
insulin secretion and is also the target for the sulfonylurea
drugs used to treat non-insulin-dependent diabetes mellitus
[2,3] and for diazoxide which inhibits insulin secretion and
is used to treat insulinoma and familial persistent hypoglycae-
mia and hyperinsulinaemia of infants (PHHI) [4]. Metabolic
regulation of KATP channels in response to an elevation of
blood glucose is mediated by an increased rate of metabolism
of the sugar within the L-cell and a consequent increase in
intracellular [ATP]/[ADP] ratio: ATP blocks the channels
whilst MgADP activates them [5]. Closure of KATP channels
in response to sulfonylureas and opening of the channels by
diazoxide involves direct binding of the drugs to the channel
[6].
The L-cell KATP channel contains two subunits, Kir6.2, an
inwardly rectifying K channel, and SUR1, which contains the
high-a⁄nity sulfonylurea binding site and whose presence in
the complex is essential for regulated channel activity [7,8].
KATP channel closure is thought to be mediated by e¡ects
of ATP on Kir6.2 [9] while SUR1 endows the channel with
sensitivity to the inhibitory e¡ects of sulfonylureas and the
stimulatory e¡ects of MgADP [10] and K channel openers
[11]. Studies on fusion constructs with ¢xed SUR1:Kir6.2
ratio suggest that the native channel has a (SUR1VKir6.2)4
stoichiometry [12,13]. A topographical model for SUR1 based
on hydrophobicity plots proposes that SUR1 contains an N-
terminal hydrophobic region (TMD0) containing ¢ve trans-
membrane helices, and two tandem repeats of six transmem-
brane helices (TMD1 and TMD2), each set followed by a
large cytosolic loop [14]. SUR1 is classi¢ed as a member of
the ATP binding cassette (ABC) superfamily and the two
cytosolic loops, each containing a Walker A and Walker B
motif [15], are suggested to function as nucleotide binding
domains (NBDs) [16]. Disruption of either NBD results in
the unregulated insulin secretion found in PHHI [17,18].
It is important to de¢ne the regions of SUR1 and Kir6.2
involved in channel assembly and ligand binding. Photoa⁄n-
ity labelling of both SUR1 and Kir6.2 by radioactive sulfo-
nylurea provided evidence for close association between the
two channel subunits [12] and a direct physical association
was demonstrated by immunoprecipitation [19]. The proximal
C-terminus of Kir6.2 has been shown to be important for
interaction with SUR1 [20]. The ¢rst transmembrane sequence
and the N-terminal region of Kir6.2 have been shown to be
important for channel assembly [21]. There is evidence that
both N- and C-termini of Kir6.2 cooperate to form the ATP
binding site [22]. The C-terminal set of transmembrane do-
mains of SUR1 has been implicated in binding of sulfonylur-
eas [23] and the ¢rst ¢ve TM domains and the C-terminus
have been shown to specify the spontaneous bursting pattern
and sensitivity to inhibition by ATP, respectively [24].
We have previously shown that functional KATP channels
can be expressed in Spodoptera frugiperda insect cells using
baculovirus [25]. In contrast to mammalian cells [8,26,27],
co-expression of SUR1 and Kir6.2 is not required in S. fru-
giperda cells for e⁄cient expression of either protein at the cell
membrane. We further demonstrated that co-expression in the
baculovirus system of two halves of SUR1 divided at Pro1042
between TM12 and 13 leads to restoration of glibenclamide
binding activity, whereas expression of either individual N- or
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C-terminal domain shows no glibenclamide binding activity
[1]. In the present study we have further examined the ability
of various SUR1 half-molecules to self-assemble and give rise
to glibenclamide binding activity. We have also examined the
in£uence of co-expression with Kir6.2 on formation of gliben-
clamide binding activity. We propose a model of KATP chan-
nel organisation based on our data and previous models.
2. Materials and methods
2.1. Cells and viruses
S. frugiperda (Sf21) cells and baculoviruses were maintained as
described before [1,25].
2.2. Construction of plasmid DNAs and recombinant baculoviruses
We constructed transfer vectors containing DNA fragments encod-
ing rat SUR1 [7] and mouse Kir6.2 [26] under control of the polyhe-
drin promoter in the pAcYM1 vector as previously described [1].
pAcNSUR2, pAcNSUR3 and pAcNSUR4 transfer vectors were ob-
tained by cloning in pAcCas1 a PCR copy of SUR1 corresponding to
amino acid (aa) sequences 55^984, 55^1125, 55^597, respectively
(pAcCas1 contains the portion of the SUR1 gene encoding aa 1^55,
a multicloning site and a His6 tag [1]. pAcNSUR1del transfer vectors
were obtained by cloning a PCR copy of SUR1 corresponding to aa
sequence 984^1042 in the NotI site of pAcSUR4. PCR products en-
coding transfer vectors pAcCSUR2 and pAcCSUR3 were obtained by
cloning PCR products encoding aa 985^1580 and 1126^1580 respec-
tively in pAcYM1. Both PCR products contain sequences encoding a
His6 tag at the 3P end. Transfer vectors were used for co-transfection
of Sf9 cells together with Autographa californica nuclear polyhedrosis
virus DNA (AcNPV PAK6) [23]. Recombinant baculoviruses
AcNPVNSUR2, AcNPVNSUR3, AcNPVNSUR4, AcNPVCSUR1-
del, AcNPVCSUR2 and AcNPVCSUR3 were obtained using the cor-
responding transfer vectors, three times plaque puri¢ed and used for
infection of Sf21 cells.
2.3. [3H]Glibenclamide binding
Sf21 cells resuspended at a density of 5U105 cells/ml in TC100 were
incubated at room temperature for 30 min with di¡erent concentra-
tions of [3H]glibenclamide (0.2^10 nM) and test substances in a ¢nal
volume of 400 Wl. The incubation was stopped by rapid separation on
Whatman GF/C ¢lters soaked in phosphate-bu¡ered saline for 30 min
beforehand. Filters were washed and speci¢c binding determined as
previously described [28].
2.4. SDS^PAGE and immunoblotting
SDS^PAGE and immunoblotting were performed as previously de-
scribed [25]. Anti-His6 tag antibodies (penta-His, Qiagen) and alkaline
phosphatase conjugated with anti-mouse antibody were used for de-
tection of His-tagged proteins. Rabbit polyclonal anti-NBD1 antisera
(dilution 1:200 000) and alkaline phosphatase conjugated with anti-
rabbit antibody were used for detection of recombinant protein con-
taining NBD1. Anti-NBD1 antisera were obtained after immunisation
of rabbits with puri¢ed NBD1 expressed in Escherichia coli [1].
3. Results and discussion
3.1. Generation of recombinant proteins
Fig. 1 illustrates the predicted topology of SUR1 and the
regions of SUR1 expressed by vectors used in this study. The
NH2-proximal half-molecule designated NSUR1, which con-
tained the ¢rst two sets of putative transmembrane domains
(TMD0 and TMD1), NBD1 and the ¢rst TM helix of the
second six-TM set, TMD2, was as described before [1]. For
the present study we constructed further NH2-proximal half-
molecules as follows: NSUR2 (TM1^11+NBD1); NSUR3
(TM1^11+NBD1+TM12^13); NSUR4 (TM1^11). A deletion
variant of NSUR1 ^ NSUR1del ^ without NBD1 was also
constructed. The COOH-proximal half-molecule designated
CSUR1, which contained the last ¢ve putative TM helices
plus NBD2, was described before [1]. For this study we con-
structed two further COOH-proximal half-molecules contain-
ing NBD2 plus either TM12^17 (CSUR2) or TM14^17
(CSUR3). All recombinant proteins were designed to contain
a His6 tag. Fig. 2 shows Western blots (using penta-His anti-
body and rabbit polyclonal anti-NBD1 antibodies) of Sf21
insect cells expressing the recombinant proteins. The positions
of the main bands on the Western blot correspond to those
predicted from amino acid sequences. Using monoclonal anti-
His antibodies gave a cleaner picture ^ ordinarily only one
band ^ but the polyclonal antiserum is more sensitive and can
be used at dilutions up to 1:1 000 000 (data not shown).
3.2. Glibenclamide binding to insect cells expressing KATP
channel recombinant proteins
As we have previously demonstrated [1,25], S. frugiperda
insect cells infected with SUR1 express glibenclamide binding
activity (Table 1, line 18). The speci¢c binding activity at 10
nM [3H]glibenclamide amounted to approximately 3U106 gli-
benclamide binding sites per cell, more than 1000-fold greater
than the density of glibenclamide binding sites in pancreatic L-
cells [28]. The glibenclamide binding a⁄nity was reduced
nearly 100-fold when Ser in position 1238 was replaced by
Tyr (Table 1, line 20), con¢rming the previously demonstrated
importance of the cytosolic loop between TM16 and TM17
for glibenclamide binding [23].
We have previously demonstrated [1] that when SUR1 was
divided between TM12 and 13 and either the N-terminal
SUR1 half-molecule (NSUR1), or the C-terminal half-mole-
cule (CSUR1) expressed separately in S. frugiperda cells, gli-
benclamide binding was not signi¢cantly greater than in cells
Fig. 1. Predicted topology of SUR1 and design of the recombinant
proteins containing regions of SUR1 used in this study. Membrane
topologies are based on [14]. Black boxes indicate the SUR1 leader
sequence. Stippled lines show SUR1 sequences used in the recombi-
nant proteins whose names are indicated on the right. Arrows indi-
cate sites on SUR1 used for generation of a SUR1 deletion mutant.
White boxes (A and B) show the location of Walker A and B mo-
tifs that can form nucleotide binding sites in each putative cytosolic
nucleotide binding domain (NBD1 and NBD2).
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infected with parent baculovirus. However, as con¢rmed here
(Table 1, line 1), in cells co-infected with both halves of SUR1
a substantial increase of glibenclamide binding activity is ob-
served. The present study demonstrates that glibenclamide
binding activity is also obtained when the SUR1 molecule is
divided at other positions. Co-expression of half-molecules
corresponding to division of SUR1 between TM13 and
TM14 (NSUR3+CSUR3) gave similar glibenclamide activity
to NSUR1+CSUR1 (Table 1, line 6). However, co-expression
of the half-molecules corresponding to division of SUR1 be-
tween NBD1 and TM12 (NSUR2+CSUR2) gave a fourfold
increase in glibenclamide binding activity (Table 1, line 4).
In order to determine whether these di¡erences re£ected
changes in the number of glibenclamide binding sites or in
a⁄nity for glibenclamide we measured glibenclamide binding
activity at di¡erent concentrations of glibenclamide. Typical
titration patterns are shown in Fig. 3. A range of di¡erent
glibenclamide binding activities ^ from high glibenclamide
binding activity (NSUR2+CSUR2) to absence of glibencla-
mide binding activity (NSUR1+CSUR3) ^ can be seen.
Data were ¢tted to the equation B = (BmaxUX/(Kd+X)+
CUX to estimate the binding a⁄nity (Kd) and number of
glibenclamide binding sites (Bmax). Some of the resulting
curves are shown in Fig. 3 and demonstrate good correlation
between ¢tted curves and experimental data. Estimated bind-
ing constants and number of binding sites per cell are shown
in Table 1. It can be seen that despite varying values of Bmax,
there is no signi¢cant di¡erence in Kd between di¡erent com-
binations of expressed proteins. All binding constants are in
the range 1.19^1.8 nM, similar to that for binding of gliben-
clamide to intact SUR1, 1.81 nM (Table 1, line 18). This
indicates that self-assembly of half SUR1 molecules leads to
the same conformation of the glibenclamide binding site as in
native SUR1. Taking in account the bivalent structure of the
glibenclamide binding site, we can conclude that the confor-
mation of SUR1 assembled from half-molecules is similar to
native SUR1.
3.3. Role of TMD12 and TMD13 in SUR1 assembly
Co-expression of halves of SUR1 divided at three di¡erent
positions (Fig. 1) ^ between NBD1 and TM11 (NSUR2 and
CSUR2); between TM11 and TM12 (NSUR1 and CSUR1);
between TM12 and TM13 (NSUR3 and CSUR3) ^ all led to
restoration of glibenclamide binding activity, but with di¡er-
ent e⁄ciency. The largest number of binding sites (863 000)
was observed when all six TM regions from the last trans-
membrane set, TMD2, were present in the COOH-part of
SUR1 (NSUR2+CSUR2, Table 1, line 4). The number of
glibenclamide binding sites was reduced when only the last
four TM helices were present in the COOH-half of SUR1 ^
270 000 glibenclamide binding sites per cell for NSUR3+
CSUR3 (Table 1, line 6). The increase in binding activity
produced when TM12 was present in the C-terminal half-mol-
ecule rather than the N-terminal half-molecule suggests that
TM12 interactions are of relevance to KATP channel assembly.
However, the number of glibenclamide binding sites remained
Fig. 2. Western blot of lysed S. frugiperda insect cells expressing
SUR1 fragments with anti-NBD1 (lanes 1^4) and anti-His6 (lane 5^
10) antisera. Lanes: 1, mock-infected cells ; 2, NSUR1; 3, NSUR2;
4, NSUR3; 5, NSUR1; 6, NSUR4; 7, NSUR1del; 8, CSUR1;
9, CSUR2; 10, CSUR3.
Table 1
Glibenclamide binding to Sf21 insect cells expressing KATP channel proteins and their fragments
Line Expressed protein Kd (nM) Bmax (binding sites/cellU1000)
1 NSUR1+CSUR1 1.52 þ 0.51 108 þ 22
2 NSUR1+CSUR1+Kir6.2 1.32 þ 0.42 211 þ 33
3 NSUR1+CSUR1+Kir4.1 1.47 þ 0.35 81 þ 17
4 NSUR2+CSUR2 1.43 þ 0.52 863 þ 41
5 NSUR2+CSUR2+Kir6.2 1.19 þ 0.24 428 þ 35
6 NSUR3+CSUR3 1.80 þ 0.51 260 þ 19
7 NSUR3+CSUR3+Kir6.2 1.21 þ 0.32 170 þ 26
8 NSUR2+CSUR1 1.39 þ 0.45 110 þ 21
9 NSUR2+CSUR1+Kir6.2 1.51 þ 0.35 91 þ 15
10 NSUR2+CSUR3 1.38 þ 0.52 253 þ 41
11 NSUR2+CSUR3+Kir6.2 1.54 þ 0.44 229 þ 35
12 NSUR1+CSUR3 No glibenclamide binding
13 NSUR1+CSUR3+Kir6.2 1.6 þ 0.37 77 þ 21
14 NSUR4+CSUR2 No glibenclamide binding
15 NSUR4+CSUR2+Kir6.2 No glibenclamide binding
16 NSUR1del+CSUR2 No glibenclamide binding
17 NSUR1del+CSUR2+Kir6.2 No glibenclamide binding
18 SUR1 1.81 þ 0.53 2990 þ 95
19 SUR1+Kir6.2 1.52 þ 0.43 1470 þ 65
20 SUR1(S1238Y) s 100 2500 þ 500
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unchanged when TM12 and TM13 regions were omitted from
the NH2-half of SUR1 ^ 239 000 glibenclamide binding sites
per cell for NSUR2+CSUR3 (Table 1, line 10) ^ indicating
that TM12 and TM13 are not essential for half SUR1 mole-
cule assembly; and TM12 and TM13 interactions with the last
four TM helices of SUR1 do not contribute to SUR1 assem-
bly. The number of glibenclamide binding sites was less when
half-molecules divided between TM11 and TM12 were co-ex-
pressed ^ 108 000 glibenclamide binding sites per cell for
NSUR1+CSUR1 (Table 1, line 1). The number of glibencla-
mide binding sites remained nearly the same ^ 110 000 gliben-
clamide binding sites per cell for NSUR2+CSUR1 (Table 1,
line 8) ^ when we removed TM12 from the NH2-half of
SUR1. However, no binding was seen when TM13 was re-
moved from the COOH-half of SUR1 (NSUR1+CSUR3, Ta-
ble 1, line 12). We interpret these data to indicate that TM12
is not tightly positioned when present in the NH2-part of
SUR1 (NSUR1) and can abolish half-molecule interaction
(NSUR1+CSUR3). The presence of TM13 in the COOH-
half of SUR1 (CSUR1) can stabilise TM12 and leads to res-
toration of SUR1 assembly (NSUR1+CSUR1). These data
indicate strong interactions between TM12 and TM13.
We therefore examined the sequence linking TM12 and
TM13. Hydropathy plots [29] of the SUR11031ÿ1060 sequence
show that this region contains a markedly hydrophobic do-
main £anked by two hydrophilic regions (Fig. 4). A number
of proteins, including Kir6.2, contain a sequence similar to the
P (pore) or H5 loop ¢rst identi¢ed in the voltage-gated K
channel family and have been shown to function as part of
the K selectivity ¢lter. The recent determination of the struc-
ture of the transmembrane domains of a related protein, the
KcsA channel of Streptomyces lividans [30], has con¢rmed this
region does indeed form the pore. Fig. 4 shows hydropathy
plots for the pore region of the K channels KcsA, Kv1.1 and
Kir6.2 and for the water pore protein aquaporin [31]. Each
contains a 30-aa sequence containing a similar hydrophilic^
hydrophobic^hydrophilic motif to SUR11031ÿ1060. We suggest,
therefore, the possibility that the loop connecting TM12 and
TM13 in SUR1 may not be entirely extracellular but may
function as a pore-like region. Interestingly, this motif is
also present in DSUR, a Drosophila homologue of SUR1
[32], but the hydrophobic domain is deleted in SUR2 [33].
3.4. Essential role of NBD1
There was no glibenclamide binding activity observed when
two half-molecules lacking NBD1 were co-expressed
(NSUR4+CSUR2, Table 1, line 14). Nor was glibenclamide
binding activity expressed when CSUR1 was co-expressed
with NSUR1del, a variant of NSUR1 lacking NBD1 (Table
1, line 16). Thus NBD1 plays a key role in SUR1 self-assem-
bly.
3.5. SUR1^Kir6.2 interaction
Consistent with our previous results [25], simultaneous ex-
pression of SUR1 and Kir 6.2 in S. frugiperda cells leads to a
decrease in number of glibenclamide binding sites ^ from
2 990 000 to 1 470 000 (Table 1, lines 18 and 19). This e¡ect
is very di¡erent from what is observed in mammalian cells
where tra⁄cking signals prevent membrane targeting of
Kir6.2 or SUR1 alone [27]. In S. frugiperda cells we have
shown that both Kir6.2 and Sur1 are independently capable
of reaching the plasma membrane [25]. Since the expression
level of SUR1 remained the same compared with expression
of SUR1 alone or co-expression of SUR1 and Kir6.2 (data
not shown), the decrease in Bmax can be attributed to inter-
ference between Kir6.2 and Kir6.2 SUR1 or SUR1 insertion
in insect cell membranes. A similar decrease in number of
Fig. 3. Glibenclamide binding to S. frugiperda insect cells expressing
di¡erent recombinant proteins. [3H]Glibenclamide binding (dpm)
was measured as described in Section 2. Data were ¢tted to the
equation B = (BmaxUX/Kd+X)+CUX, where B = number of bound
glibenclamide molecules per cell, X = concentration of glibenclamide
(nM), Bmax = total number of glibenclamide binding sites per cell,
Kd = constant of binding (nM), C = coe⁄cient characterising
unspeci¢c binding to ¢lter. a, NSUR2+CSUR2; E, NSUR2+
CSUR2+Kir6.2; U, NSUR1+CSUR1+Kir6.2; +, NSUR1+CSUR1;
O, NSUR1+CSUR3+Kir6.2; 7, NSUR1+CSUR3.
Fig. 4. Hydropathy plots for SUR11031ÿ1060, a putative pore-like re-
gion. In addition to SUR11031ÿ1060, the ¢gure shows hydropathy
plots [29] for the pore region of the K channels KcsA, Kv1.1, and
Kir6.2 as well as the water pore protein, aquaporin. The ¢gure also
shows hydropathy plots for the corresponding regions of DSUR
and SUR2.
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glibenclamide binding sites was obtained when NSUR2+
CSUR2 were co-expressed with Kir6.2 ^ from 863 000 to
428 000 glibenclamide binding sites per cell (Table 1, lines 4
and 5); or when NSUR3+CSUR3 were co-expressed with
Kir6.2 ^ from 270 000 to 170 000 sites per cell (Table 1, lines
6 and 7). However, an increased number of glibenclamide
binding sites ^ from 108 000 to 211 000 sites per cell ^ was
obtained after co-expression of NSUR1+CSUR1 with Kir6.2
(Table 1, lines 1 and 2). This interaction is speci¢c to Kir6.2
because when we used Kir4.1 instead of Kir6.2 no increase of
glibenclamide binding sites was observed (Table 1, line 3). In
view of the previously proposed instability of TM12 in
NSUR1 these data suggest that Kir6.2 interacts with TM12
to facilitate assembly of NH2- and COOH-parts of SUR1.
Additional con¢rmation of this proposal was obtained after
investigation of NSUR1+CSUR3 expression; only when co-
expressed with Kir6.2 was a signi¢cant number of glibencla-
mide binding sites observed ^ 77 000 (Table 1, lines 12 and
13).
3.6. A model for the L-cell KATP channel
There is growing evidence on the regions of KATP channel
subunits which may interact to form the active channel. Since
the fusion protein SUR1^Kir6.2 leads to active KATP channels
[12,13,34] it seemed likely that in the native protein there is
close juxtaposition of the C-terminus of SUR1 and the N-
Fig. 5. Model of KATP channel. The upper panel shows the suggested transmembrane topology of the L-cell KATP channel. The lower panel
provides cross-sectional views within the membrane (A) and within the cytosol (B). The key features of the model are: (i) within each SUR1^
Kir6.2 pair: interactions between NBD1 and NBD2, between NBD2 and Kir6.2, between SUR1 TM12 and TM13, between SUR1 TM12 and
Kir6.2, and between the N- and C-terminal cytosolic regions of Kir6.2; (ii) between neighbouring SUR1^Kir6.2 pairs: interactions between
NBD1. The model also shows the presumed internal location of Kir6.2 to form the permeation pathway, and incorporates the suggestion that
the sequence of SUR1 between TM12 and TM13 may be a pore-like region.
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terminus of Kir6.2. Using an in vitro protein^protein interac-
tion assay it has been demonstrated that the two intracellular
domains of Kir6.2 do mutually interact [35]. A highly con-
served region within the N-terminus is responsible for this
interaction and a mutation within this region (G40D) which
disrupts the interaction severely interferes with the ability of
Kir6.2 to form a functional KATP channel.
There is evidence for a direct interaction between Kir6.2
and SUR1. From a mixture of Kir6.2 and SUR1 in vitro
translated proteins, and from COS cells transfected with
both channel subunits, a Kir6.2-speci¢c antibody co-immuno-
precipitated Kir6.2 and SUR1 [19]. Kir6.2vC37 also co-
immunoprecipitated with SUR1, suggesting that the distal
carboxy-terminus of Kir6.2 is unnecessary for subunit
association. However, a co-immunoprecipitation approach in
HEK293 cells stably transfected with SUR1 and Kir6.2 sug-
gested that a domain in the C-terminus of Kir6.2 (amino acids
208^279) was involved in biochemical interaction with SUR1
[20]. The domain, while necessary, was not su⁄cient, however,
and full reconstitution of KATP channels required largely in-
tact N- and C-termini. A requirement for a proximal C-ter-
minal domain has also been observed for association of Kir6.2
and SUR2A [36]. However, a study using a tra⁄cking-based
assay for detection of interactions showed that either TM1 or
the N-terminus of Kir6.2 was su⁄cient for conferring assem-
bly with SUR1 [21]. This study also indicated that Kir6.2
interacts with transmembrane domains of SUR1. Consistent
with these observations our data further suggest that TM12 of
SUR1 interacts with Kir6.2.
We have previously provided evidence for an interaction
between NBD1 and NBD2 [1]. NBD1 expressed in Sf9 cells
as a green £uorescent protein (GFP) fusion protein was dis-
tributed throughout the cell. After co-expression of NBD1^
GFP with the C-terminal half of SUR1, NBD1^GFP was
localised near the plasma membrane. This e¡ect disappeared
when NBD2 was deleted from the C-terminal fragment indi-
cating strong interaction between NBD1 and NBD2. Co-ex-
pression of NBD1^GFP with Kir6.2 did not localise NBD1^
GFP to the plasma membrane suggesting a lack of strong
interaction between Kir6.2 and NBD1. We have also previ-
ously shown that puri¢ed NBD1 alone shows a marked ability
to form a tetramer [1], suggesting that self-interactions be-
tween NBD1 in di¡erent subunits contribute to channel as-
sembly. The present study further supports such an essential
role for NBD1.
Fig. 5 presents a model for KATP channel structure based
upon the interactions suggested by these data.
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